Status:
COMPLETED
T Cell Interferon-gamma Release Assay (TIGRA) in Immunocompromised Individuals
Lead Sponsor:
Tuberculosis Network European Trialsgroup
Conditions:
Tuberculosis
Monitoring, Immunologic
Eligibility:
All Genders
18+ years
Brief Summary
Until recently, the tuberculin skin test (TST) was the only available diagnostic assay for detection of latent infection with M. tuberculosis (LTBI). Despite the low overall incidence of symptomatic t...
Detailed Description
Until recently, the tuberculin skin test (TST) was the only available diagnostic assay for detection of latent infection with M. tuberculosis (LTBI). Despite the low overall incidence of symptomatic t...
Eligibility Criteria
Inclusion
- Individual as specified for the study population
- Written informed consent
- Indication to perform tuberculin skin test(suspect latent infection, according to standard guidelines, differential diagnosis)
Exclusion
- \<18 years of age
Key Trial Info
Start Date :
June 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
1843 Patients enrolled
Trial Details
Trial ID
NCT00707317
Start Date
June 1 2008
End Date
May 1 2011
Last Update
December 16 2015
Active Locations (21)
Enter a location and click search to find clinical trials sorted by distance.
1
Cellestis Limited
Carnegie, Australia
2
National Center of Infectious and Parasitic Diseases
Sofia, Bulgaria
3
Herlev Hospital
Herlev, Denmark
4
Research Center Borstel
Borstel, Germany